Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00898508 · ClinicalTrials.gov registry record
Studying Blood and Tumor Tissue Samples in Women With Invasive Breast Cancer, Ductal or Lobular Carcinoma in Situ, or Benign Breast Disease
A clinical trial, sponsored by City of Hope Medical Center.
- Completed
- Registry status
- 563
- Enrollment target
NCT00898508: Completed study, sponsored by City of Hope Medical Center.
NCT00898508 is a clinical trial that has completed, run by City of Hope Medical Center. The registered enrollment target is 563 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00898508 has completed, sponsored by City of Hope Medical Center.
- COMPLETED
- Registry status
- 563 participants
- Enrollment target
Study Summary
RATIONALE: Collecting and storing samples of blood and tumor tissue from patients with cancer to test in the laboratory may help the study of cancer in the future. PURPOSE: This clinical trial is studying blood and tumor tissue samples in women with invasive breast cancer, ductal carcinoma in situ, lobular carcinoma in situ, or benign breast disease.
Interventions
- GENETIC gene expression analysis
- GENETIC mutation analysis
- GENETIC reverse transcriptase-polymerase chain reaction
- GENETIC proteomic profiling
- OTHER fluorescent antibody technique
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 563 participants |
| Start Date | 2005-08 |
| Est. Completion | 2019-06-06 |
What the finished NCT00898508 record still lists
NCT00898508 is an observational study that tracks outcomes without assigning an intervention. The registered 563 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 5 interventions - of which gene expression analysis is the first listed.
NCT00898508 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00898508 about?
NCT00898508 is a clinical study titled "Studying Blood and Tumor Tissue Samples in Women With Invasive Breast Cancer, Ductal or Lobular Carcinoma in Situ, or Benign Breast Disease". RATIONALE: Collecting and storing samples of blood and tumor tissue from patients with cancer to test in the laboratory may help the study of cancer in the future. PURPOSE: This clinical trial is studying blood and tumor tissue samples in women with invasive breast cancer, ductal carcinoma in situ,...
What is the current status of trial NCT00898508?
This trial is currently completed. The enrollment target is 563 participants. The study started on 2005-08. Estimated completion is 2019-06-06.
What interventions are being tested in trial NCT00898508?
The interventions under investigation include: gene expression analysis (GENETIC), mutation analysis (GENETIC), reverse transcriptase-polymerase chain reaction (GENETIC), proteomic profiling (GENETIC), fluorescent antibody technique (OTHER).
Who is sponsoring clinical trial NCT00898508?
This trial is sponsored by City of Hope Medical Center, which has 582 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06146725 · 564 participants
The RESBIOP-study: Resection Versus Biopsy in High-grade Glioma Patients (ENCRAM 2202)
- NCT06188520 · 564 participants · Phase 1
A First-in-human Dose Escalation and Expansion Study to Evaluate the Safety, and Tolerability of AZD8421 Alone or in Combination in Participants With Selected Advanced or Metastatic Solid Tumors
- NCT06628453 · 564 participants · NA
CGM for Management of Type 2 Diabetes in Pregnancy
- NCT07125326 · 564 participants · NA
How the Method of Bladder Emptying After Epidural Placement in Labor Affects Postpartum Voiding
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia